Overview

Update
Total Equity Funding
$3M in 2 Rounds
Most Recent Funding
$750k Debt Financing on March 18, 2016
Headquarters:
Santa Monica, CA
Description:
Arrogene is a development stage company that develops nano-biopolymers and related technologies for cancer therapeutics and diagnostics.
Founders:
Categories:
Biotechnology, Health Diagnostics
Website:
http://arrogene.com
Social:

Company Details

Update

Arrogene, Inc., a development stage company, engages in developing nano-biopolymers and related technologies cancer therapeutics and diagnostics in the United States. Its products include nanopolymer Polycefin that is in pre-clinical development to block Laminin-411 production in primary and metastatic brain and breast tumors; Laminin-411, a diagnostic tool for advanced brain glioma and as a prognostic indicator that predicts disease recurrence; and Laminin-421. The company was founded in 2007 and is based in Santa Monica, California.

Funding Rounds (6) - $4.67M

Update
DateAmount / RoundValuationLead InvestorInvestors
Mar, 2016$750k / Debt Financing0
Jan, 2015$250k / Debt Financing0
Mar, 2014$170k / Debt Financing0
Jun, 2013$2.27M / Venture0
Mar, 2011$496.55k / Debt Financing0
Oct, 2010$726.55k / Venture0

Current Team (4)

Update

News (6)

Update
DateNews
Mar 21, 2016SEC - UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Mar 1, 2015SEC - SEC FORM D
Mar 9, 2014SEC - SEC FORM D
Nov 20, 2013SEC - SEC FORM D/A
Nov 12, 2013SEC - SEC FORM D/A
Jun 14, 2013SEC - SEC FORM D/A

Offices/Locations (1)

Update
  • Office

    2500 Broadway

    Santa Monica, CA 90404

    USA

Images (2)

Update

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos